Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Robotic radiosurgery system has treated more than 2,000 lung cancer patients

Accuray : 03 April, 2007  (New Product)
Accuray’s CyberKnife Robotic Radiosurgery System has been used to treat more than 2,000 lung cancer patients worldwide.
The company also reported that the first patient was treated using the recently introduced Xsight Lung Tracking System, a system that works with the CyberKnife System to precisely track and treat some lung tumours non-invasively.

The CyberKnife System reached the 2,000 patient milestone so rapidly because it is the only dedicated Radiosurgery system capable of treating tumours anywhere in the body. By expanding Radiosurgery beyond intracranial tumours, the CyberKnife System gives hope to more cancer patients, including patients who oppose surgery or who were previously considered inoperable. The addition of the Xsight Lung Tracking System now extends this treatment opportunity to an even larger patient population, such as older patients and those who may not be able to tolerate the invasive implantation of fiducials.

'In the three and a half years I have been treating primary and metastatic lung tumours with the CyberKnife System, the clinical results have been impressive,' said John Kresl, MD, PhD, St Joseph's Hospital and Barrow Neurological Institute in Phoenix, Arizona, USA. 'In fact, the results are so good that in some of the early cases, the CT scan obtained after the CyberKnife treatment were indistinguishable from those achieved with surgery. The CyberKnife System gives patients who cannot or do not want to undergo surgery the best non-invasive, pain-free treatment option with the least side effects or risk for reduced lung function.'

“The CyberKnife System is unique in its ability to accurately treat lung tumours that move with respiration,” said Mark Brenner, MD, chief of the department of radiation oncology at Sinai Hospital in Baltimore, Maryland, USA. “When lung tumour procedures require the implantation of fiducials, almost one-third of patients experience pneumothorax. The CyberKnife System's Xsight Lung Tracking System enables us to reduce this risk and other painful complications inherent to these treatments.”

According to the American Cancer Society (ACS), lung cancer is the leading cause of cancer-related deaths in the United States and will account for approximately 29 percent of all cancer deaths in 2007. In fact, each year almost twice as many women die from lung cancer than from breast cancer. The ACS projects that more than 213,000 new cases of lung cancer will be discovered this year, accounting for 15 percent of all cancer diagnoses.

“The CyberKnife System is the first and only Radiosurgery treatment that can precisely target a number of lung tumours without invasive procedures, debilitating side effects or a long, painful recovery period,” said Euan S Thomson, PhD, president and CEO of Accuray. “The fact that this innovative treatment has now been used to treat more than 2,000 lung cancer patients is a testament to the impact Radiosurgery is having in the battle against cancer. With the CyberKnife System, cancer patients now have a non-surgical option, which gives them new hope for a quick and complication-free recovery.”

“After a long, painful recovery from the surgery that removed my first lung tumour, I elected to have the second tumour removed non-invasively using the CyberKnife System,” said Joan Schwab, who was diagnosed with Stage IV cancer in both lungs. “The CyberKnife treatment was very easy. I relaxed and slept during the treatment and was able to return to work immediately. I had no side effects and am grateful for the CyberKnife.”
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo